EMCC European Monitoring Centre on Change

Biomedical cluster

21 Oct, 2016
    • Ireland
  • Organisation size


  • Establishment size


  • Type of restructuring
    • Internal restructuring
  • Ownership
    • Private
  • Sectors
    • Chemicals
  • Involved actors

    • Business partners/supply chain
    • National government
  • Anticipation of change activities
    • Establishment of networks/partnerships with regular exchange facilities
    • Continuous mapping of jobs and skills needs - Elaboration of training plans
    • R&D - innovation
Since the 1960s, Ireland has developed a globally significant life sciences industry, including the pharmaceutical/chemical, biopharmaceuticals, medical devices and diagnostics sectors. Each of these sectors is represented in Ireland by industry leaders such as Pfizer, GlaxoSmithKline, Takeda, Merck, Genzyme, Gilead, Medtronic, Boston Scientific, Abbott and many others. Today, the Irish life science industry consists of over 170 companies. A modern specialist infrastructure has grown up to support and develop these industry sectors and activities. This, combined with a good operating environment, full access to the European market and fiscal advantages, makes Ireland the location of choice of many companies.
  • Regional aspects
  • Knowledge-intensive business sector
  • Clusters/Networks/Supply chains